ComboMATCH trial—a collaboration across NCI and NCTN groups—matches patients with combination therapy trials based on tumor biology

LSU LCMC Health cancer center researchers receive $3.1M NIH grant to study pancreatic cancer

LSU Health New Orleans received a five-year, $3.1 million NIH grant to support pancreatic cancer research led by investigators in the LSU LCMC Health Cancer Center.

July 17, 2026

Vol.52 No.28

Clinical Trials & Tribulations

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research.

July 10, 2026

Vol.52 No.27

By Enrique Velazquez-Villarreal

In Brief

Ned Sharpless’s portrait unveiled at FNIH ceremony

Former NCI director Norman “Ned” Sharpless had his portrait unveiled at a ceremony hosted by the Foundation for the National Institutes of Health on the main NIH campus in Bethesda.

July 10, 2026

Vol.52 No.27

Podcast The Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.

June 26, 2026

Vol.52 No.25

By Paul Goldberg and Claire Marie Porter

Cancer Policy

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

Democratic leaders of the House Committee on Energy and Commerce are urging NIH Director Jay Bhattacharya to voice objections to a proposed rule from the Office of Management and Budget that would give the administration unprecedented political control over government-funded science.

FDA clears a way for dramatic reduction in animal toxicology studies in cancer

FDA has issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for some cancer pharmaceuticals.

June 18, 2026

Vol.52 No.24

By Claire Marie Porter

ComboMATCH trial—a collaboration across NCI and NCTN groups—matches patients with combination therapy trials based on tumor biology

YOU MAY BE INTERESTED IN

LSU LCMC Health cancer center researchers receive $3.1M NIH grant to study pancreatic cancer

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

Ned Sharpless’s portrait unveiled at FNIH ceremony

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

FDA clears a way for dramatic reduction in animal toxicology studies in cancer

Renew today!

Subscriber content

Never miss an issue!

Login

ComboMATCH trial—a collaboration across NCI and NCTN groups—matches patients with combination therapy trials based on tumor biology

YOU MAY BE INTERESTED IN

LSU LCMC Health cancer center researchers receive $3.1M NIH grant to study pancreatic cancer

The challenge of making the move from conversational AI to autonomous scientific discoveryAdvancing from level II to level III AI agents in precision medicine

Ned Sharpless’s portrait unveiled at FNIH ceremony

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas“Institutions are feeling crunched in so many different directions”

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

FDA clears a way for dramatic reduction in animal toxicology studies in cancer

Never miss an issue!

Login

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”